Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Anton Bespalov*, Thomas Steckler, Bruce Altevogt, Elena Koustova, Phil Skolnick, Daniel Deaver, Mark J. Millan, Jesper F. Bastlund, Dario Doller, Jeffrey Witkin, Paul Moser, Patricio O'Donnell, Ulrich Ebert, Mark A. Geyer, Eric Prinssen, Theresa Ballard, Malcolm Macleod

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Number of pages1
JournalNature Reviews Drug Discovery
Issue number7
Publication statusPublished - 30 Jun 2016

Cite this